https://pharmoniq.com/news/fda-approves-daraxonrasib-pancreatic-cancer-breakthrough PharmoniQ en 2026-09-03T14:10:49.810Z FDA Approves Daraxonrasib for Pancreatic Cancer Treatment pancreatic cancer, FDA approval, oncology, breakthrough therapy, daraxonrasib https://pharmoniq.com/news/royalty-pharma-zealand-rusfertide-funding-deal PharmoniQ en 2026-09-03T08:47:03.152Z Royalty Pharma Commits $100M to Zealand's Rusfertide Program royalty pharma, zealand pharma, rusfertide, polycythemia vera, rare disease https://pharmoniq.com/news/pg-acquires-thorne-supplement-consolidation PharmoniQ en 2026-09-02T14:10:50.105Z P&G Acquires Thorne in Major Supplement Consolidation Play mergers-acquisitions, industry-consolidation, supplement-market, procter-gamble, thorne